Journal of Cardiovascular Electrophysiology

NOVEMBER 27, 2023

However, ventricular arrhythmias (VA) are common, are mostly secondary to underlying myocardial scar, and have a higher incidence in patients with pre-LVAD VA.

Defibrillator 40

Defibrillator Arrhythmia Best Practices Quality of Life 40

HeartRhythm

APRIL 30, 2024

The Extravascular Implantable Cardioverter Defibrillator (EV ICD) has demonstrated to be efficacious in the treatment of ventricular arrhythmias. Predicators of lead rotation have yet to be elucidated. The management of patients affected by lead rotation is of clinical significance and not yet described.

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

SEPTEMBER 16, 2024

Implantable cardioverter-defibrillators (ICDs) are established as the standard of care for patients who are deemed at increased risk of life-threatening ventricular arrhythmias. Device-specific fears and symptoms of anxiety are the most common psychological sequelae experienced by ICD patients.1

Defibrillator 40

Defibrillator Quality of Life Arrhythmia 40

HeartRhythm

MAY 23, 2024

Despite the implantable cardioverter defibrillator’s (ICD) effectiveness in saving patients with life-threatening ventricular arrhythmias (VAs), the temporal occurrence of VA following ICD implantation is unpredictable.

Arrhythmia 40

Arrhythmia Defibrillator 40

HeartRhythm

APRIL 30, 2024

Ventricular arrhythmias and heart failure are common presentations of cardiac sarcoidosis (CS). Guidelines support implantable cardioverter-defibrillator (ICD) for many CS patients with reduced ejection fraction, but arrhythmic outcomes are poorly understood.

Defibrillator 40

Defibrillator Heart Failure Arrhythmia Outcomes 40

HeartRhythm

AUGUST 31, 2024

Implantable cardioverter defibrillators (ICD) are effective at terminating ventricular arrhythmias (VA), though have significant drawbacks. The opportunity to predict the onset of arrhythmia holds promise for insight into VA initiation and the opportunity to deliver therapy prior to an event.

Arrhythmia 40

Arrhythmia Defibrillator 40

HeartRhythm

OCTOBER 24, 2024

Less is known about the relationship between NAFLD, ventricular arrhythmias (VAs), and cardiovascular events. Patients with nonalcoholic fatty liver disease (NAFLD) are at risk for cardiovascular diseases.

Arrhythmia 40

Arrhythmia Defibrillator Cardiovascular Disease 40

HeartRhythm

JULY 14, 2024

The feasibility and safety of utilizing LBBAP lead to provide sensing of ventricular arrhythmia in patients receiving implantable cardioverter defibrillator(ICD) with CRT has been demonstrated recently

Defibrillator 40

Defibrillator Arrhythmia 40

Medical Xpress - Cardiology

APRIL 10, 2024

The late-breaking science was presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

Ablation 74

Ablation Hospital Tachycardia Defibrillator 74

Dr. Smith's ECG Blog

JULY 25, 2024

He was defibrillated into VT. He then underwent dual sequential defibrillation into asystole. See these related cases: Cardiac arrest, defibrillated, diffuse ST depression and ST Elevation in aVR. This patient was witnessed by bystanders to collapse. They started CPR. EMS arrived and found him in Ventricular Fibrillation (VF).

Cardiac Arrest 124

Cardiac Arrest Ischemia Tachycardia Defibrillator 124

HeartRhythm

DECEMBER 31, 2023

This 1997 figure is the first conclusive evidence that the implantable cardioverter-defibrillator (ICD) reduces overall mortality compared with drugs in patients with life-threatening ventricular arrhythmias (from The New England Journal of Medicine, reprinted with permission from Massachusetts Medical Society).1

Defibrillator 40

Defibrillator Arrhythmia 40

HeartRhythm

FEBRUARY 22, 2024

Arg14del) variant carriers are at risk of developing malignant ventricular arrhythmias (MVA). Accurate risk stratification allows for timely implantation of intracardiac defibrillators (ICD) and is currently performed using a multimodality prediction model. Phospholamban (PLN) p.(Arg14del)

Arrhythmia 40

Arrhythmia Defibrillator Cardiomyopathy 40

European Journal of Heart Failure

MARCH 19, 2025

During AHF, there is an increased risk of destabilizing the functional substrate and modulatory adding to the risk of ventricular arrhythmias (VAs) already created by the structural substrate. Scientific guidelines provide clear recommendations for the management of arrhythmias in chronic heart failure patients.

Heart Failure 40

Heart Failure Cardiogenic Shock Arrhythmia Heart Rhythm 40

HeartRhythm

APRIL 30, 2024

Consequent implantable cardioverter-defibrillator (ICD) shocks can tremendously affect quality of life. Stereotactic arrhythmia radioablation (STAR) seems to reduce the number of ICD/external shocks, although most studies on STAR published to date only report results up to 12 months.

Arrhythmia 40

Arrhythmia Quality of Life Defibrillator Tachycardia 40

Journal of Cardiovascular Electrophysiology

JANUARY 29, 2024

Abstract The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the traditional transvenous implantable cardioverter defibrillator (TV-ICD), aiming to provide easier implantation, simplified detection algorithm of malignant ventricular arrhythmias and prevention from placing components in the cardiovascular (..)

Defibrillator 40

Defibrillator Electrocardiogram Technology Arrhythmia 40

DAIC

MARCH 26, 2024

The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Pacemakers and implantable cardioverter defibrillators (ICDs) are the standard of care to regulate a patient’s irregular heartbeat. million people in the United States by 2030, based on an estimation from the Centers for Disease Control and Prevention.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundScreening for atrial fibrillation (AF) may reveal incidental arrhythmias of relevance. We furthermore report treatment decisions because of incidental arrhythmias. We found incidental arrhythmias in 94 patients (11.8%). Journal of the American Heart Association, Ahead of Print. of our cohort patients.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Hospital Tachycardia 40

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

ABSTRACT Aim To evaluate the predictive value of preoperative echocardiographic parameters for occurrence of VAs in patients with preexisting ICD undergoing LVAD implantation. Methods and Results All consecutive patients ( n =264) with previous ICD who underwent LVAD surgery between May 2011 and December 2019 at our institution were included.

Defibrillator 40

Defibrillator Arrhythmia Tricuspid Bicuspid/Mitral 40

HeartRhythm

APRIL 30, 2024

We conducted this systematic review and meta-analysis to evaluate safety outcomes including risk of ventricular arrhythmias, new onset atrial fibrillation, Implantable Cardiac defibrillators (ICD) shocks, QRS duration reduction, heart failure hospitalizations and mortality.

Heart Failure 40

Heart Failure Arrhythmia Atrial Fibrillation Defibrillator 40

HeartRhythm

APRIL 30, 2024

The efficacy of implantable cardioverter-defibrillators (ICD) in patients with a non-ischaemic cardiomyopathy (NICM) is being debated. Deep Learning models enable feature extraction from high-dimensional data, such as cardiac MRI (CMR) and ECG.

Cardiomyopathy 40

Cardiomyopathy Defibrillator Arrhythmia 40

Circulation

JULY 10, 2024

The rapid technological advancements in cardiac implantable electronic devices such as pacemakers, implantable cardioverter defibrillators, and loop recorders, coupled with a rise in the number of patients with these devices, necessitate an updated clinical framework for periprocedural management.

Defibrillator 49

Defibrillator Pacemaker Technology Nursing 49

HeartRhythm

MARCH 12, 2024

Many patients with mild to moderately reduced left ventricular ejection fraction (LVEF) that require permanent pacemaker (PPM) implantation do not have a concurrent indication for implantable cardioverter-defibrillator (ICD) therapy. However, the risk of ventricular tachycardia/fibrillation (VT/VF) in this population is unknown.

Pacemaker 40

Pacemaker Defibrillator Arrhythmia Tachycardia 40

HeartRhythm

APRIL 30, 2024

Non-sustained ventricular tachycardia (NSVT) is a predictor of sustained ventricular arrhythmias (VA) among implantable cardioverter defibrillator (ICD) recipients. We hypothesized that that a history of NSVT in primary prevention ICD recipients may parallel the risk profile observed in secondary prevention ICD recipients.

Tachycardia 40

Tachycardia Defibrillator Arrhythmia Outcomes 40

All About Cardiovascular System and Disorders

APRIL 17, 2024

Ventricular tachycardia is a potentially life threatening cardiac arrhythmia. Recurrent ventricular tachycardia in spite of radiofrequency catheter ablation needs an implantable cardioverter defibrillator. If the rate is very fast, hemodynamic deterioration can occur rapidly.

Tachycardia 52

Tachycardia Defibrillator Congenital Ischemia 52

Dr. Smith's ECG Blog

JANUARY 2, 2025

Because she has cardiomyopathy and ventricular dysrhythmias, the pacer included an Implanted Cardioverter-Defibrillator (ICD) Echo 6 days later after CRT: Normal estimated left ventricular ejection fraction. The septum is punctured with the active fixation screw of the lead - so essentially you bore the septum with the screw helix."

Tachycardia 116

Tachycardia Cardiomyopathy Blog Bradycardia 116

DAIC

JUNE 19, 2024

They include medications that are not very effective and cause unpleasant side effects, an implantable cardioverter-defibrillator (or ICD) that provides an internal shock to correct the heartbeat, and a procedure called catheter ablation. Right now, there are several treatment options, but none of them are optimal.

Tachycardia 128

Tachycardia Cardiac Arrest Ablation Research 128

HeartRhythm

JULY 22, 2024

1 A rare but significant issue in post-OHT patients is ventricular arrhythmias, in extreme cases leading to cardiac arrest and implantation of an implantable cardioverter-defibrillator (ICD) for secondary prevention. Rarely, implantation of cardiac implantable electronic devices (CIEDs) becomes necessary.1

Heart Transplant 40

Heart Transplant Transplant Cardiac Arrest Defibrillator 40

HeartRhythm

APRIL 30, 2024

Loss-of-function SCN5A channelopathies, such as Brugada syndrome (BrS), are cardiac disorders marked by diminished sodium current (INa), conduction slowing, and lethal arrhythmias.

Pharmacology 40

Pharmacology Defibrillator Innovation Arrhythmia 40

Dr. Smith's ECG Blog

SEPTEMBER 27, 2023

After amiodarone and several defibrillations and about 20 minutes after initial arrest, stable ROSC was achieved. Of academic interest — are the arrhythmias that developed. The Arrhythmia Lesson to be Learned: I was not initially confident about my interpretation of the rhythm in today's 5 tracings.

Tachycardia 132

Tachycardia Chest Pain Academic Arrhythmia 132

All About Cardiovascular System and Disorders

MAY 1, 2024

ICD is short form for implantable cardioverter defibrillator, used to automatically shock back the heart into action in case of life threatening ventricular arrhythmias. CRT-D is needed in some heart failure patients who have a high risk of life threatening ventricular arrhythmias.

Heart Failure 52

Heart Failure Arrhythmia Pacemaker Defibrillator 52

Dr. Smith's ECG Blog

OCTOBER 23, 2023

She was successfully revived after several rounds of ACLS including defibrillation and amiodarone. T-wave alternans and the susceptibility to ventricular arrhythmias. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Pacing Clin Electrophysiol.

Tachycardia 130

Tachycardia Cardiac Arrest ICU Blog 130

Circulation

NOVEMBER 11, 2024

This can initiate ventricular arrhythmias like polymorphic ventricular tachycardia (PMVT). She was externally defibrillated with 200J and received magnesium and an IV amiodarone bolus. She was successfully defibrillated with 360J. Circulation, Volume 150, Issue Suppl_1 , Page A4143264-A4143264, November 12, 2024.

Tachycardia 40

Tachycardia Pacemaker Defibrillator Atrial Fibrillation 40

Dr. Smith's ECG Blog

SEPTEMBER 16, 2024

After resuscitation and defibrillation , there were no more episodes of TdP. Below is the patient’s 12 lead ECG following defibrillation. Learning points : Takotsubo can lead to cardiac arrest from ventricular arrhythmia. NT-proBNP was significantly elevated at 4900ng/L ( ref < 500ng/L ). What does this ECG tell you?

Cardiac Arrest 67

Cardiac Arrest Cardiomyopathy Arrhythmia Atrial Fibrillation 67

Circulation: Arrhythmia and Electrophysiology

JANUARY 29, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:There is no specific treatment for sudden cardiac arrest (SCA) manifesting as pulseless electric activity (PEA) and survival rates are low; unlike ventricular fibrillation (VF), which is treatable by defibrillation.

Cardiac Arrest 40

Cardiac Arrest Chest Pain Coronary Artery Disease Defibrillator 40

Ken Grauer, MD

MARCH 23, 2023

She underwent cardiopulmonary resuscitation for VT/VFib — with ROSC ( R eturn O f S pontaneous C irculation ) following defibrillation and treatment with Epinephrine and Amiodarone. A series of cardiac arrhythmias were seen during the course of her resuscitation — including the interesting arrhythmia shown in the long lead II of Figure-1.

Blog 78

Blog Tachycardia Arrhythmia Atrial Flutter 78

Dr. Smith's ECG Blog

MARCH 15, 2023

We examined the effect of ibutilide, a class III antiarrhythmic agent, on the energy requirement for atrial defibrillation and assessed the value of this agent in facilitating cardioversion in patients with atrial fibrillation that is resistant to conventional transthoracic cardioversion. 25, 2022 ).

Atrial Fibrillation 52

Atrial Fibrillation AFIB Arrhythmia Exercise 52

Wellnest

JUNE 19, 2023

Alternatively, it also helps enhance arrhythmia management with coronary artery disease. Along with it, a guideline-based algorithm helps identify implantable cardioverter defibrillators. Machine learning featured system also creates a scope for predicting major cardiac events handily and improves arrhythmia management.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52